David M. Jackman
Impact in
- Pulmonary and Respiratory Medicine top 0.1%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Oncology top 0.5%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
Papers in
-
- Lung Cancer Treatments and Mutations 48
- Lung Cancer Diagnosis and Treatment 13
- Occupational and environmental lung diseases 5
- Oncology 24
- Lung Cancer Research Studies 11
- Colorectal Cancer Treatments and Studies 8
- HER2/EGFR in Cancer Research 5
- Co-authors
- Bruce E. Johnson (36 shared papers)Pasi A. Jänne (40 shared papers)Geoffrey R. Oxnard (18 shared papers)Beow Y. Yeap (18 shared papers)Suzanne E. Dahlberg (14 shared papers)Lecia V. Sequist (16 shared papers)Neal I. Lindeman (10 shared papers)Mohit Butaney (10 shared papers)
- Journals
- Journal of Clinical Oncology (30 papers)Clinical Cancer Research (10 papers)Journal of Thoracic Oncology (7 papers)Lung Cancer (5 papers)Cancer (4 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
David M. Jackman
87 papers receiving 7.5k citations
David M. Jackman's Hit Papers
Peers
Comparison fields: 5 of 123
- Pulmonary and Respiratory Medicine 4.7k
- Oncology 3.4k
- Cancer Research 1.2k
- Molecular Biology 1.6k
- Hepatology 141
Countries citing papers authored by David M. Jackman
This map shows the geographic impact of David M. Jackman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Jackman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Jackman more than expected).
Fields of papers citing papers by David M. Jackman
This network shows the impact of papers produced by David M. Jackman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Jackman. The network helps show where David M. Jackman may publish in the future.
Co-authors
The 25 scholars most cited alongside David M. Jackman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Definition of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer Hit paper breakdown → | 2009 | 646 |
| 2 | Noninvasive Detection of Response and Resistance in EGFR -Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA Hit paper breakdown → | 2014 | 596 |
| 3 | Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: Results From the CA209-003 Study Hit paper breakdown → | 2018 | 545 |
| 4 | MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression Hit paper breakdown → | 2016 | 499 |
| 5 | Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib Hit paper breakdown → | 2006 | 492 |
| 6 | 2005 | 407 | |
| 7 | 2009 | 312 | |
| 8 | 2013 | 266 | |
| 9 | 2015 | 255 | |
| 10 | 2007 | 254 | |
| 11 | 2015 | 213 | |
| 12 | 2006 | 205 | |
| 13 | 2010 | 177 | |
| 14 | 2015 | 176 | |
| 15 | 2010 | 160 | |
| 16 | 2012 | 144 | |
| 17 | 2008 | 139 | |
| 18 | 2014 | 111 | |
| 19 | 2013 | 104 | |
| 20 | 2008 | 96 |
About David M. Jackman
David M. Jackman is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Public Health, Environmental and Occupational Health, Economics and Econometrics and Epidemiology, having authored 88 papers that have together received 7.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (48 papers), Lung Cancer Diagnosis and Treatment (13 papers), Lung Cancer Research Studies (11 papers), Colorectal Cancer Treatments and Studies (8 papers), Clinical practice guidelines implementation (6 papers), Cancer Genomics and Diagnostics (5 papers), Occupational and environmental lung diseases (5 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.7k citations), Oncology (3.4k citations), Cancer Research (1.2k citations), Molecular Biology (1.6k citations) and Hepatology (141 citations). David M. Jackman has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Bruce E. Johnson, Pasi A. Jänne, Geoffrey R. Oxnard, Beow Y. Yeap, Suzanne E. Dahlberg, Lecia V. Sequist, Neal I. Lindeman, Mohit Butaney, Michael S. Rabin and Thomas J. Lynch. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Journal of Thoracic Oncology, Lung Cancer and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.